ATE456956T1 - Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln - Google Patents
Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimittelnInfo
- Publication number
- ATE456956T1 ATE456956T1 AT03727053T AT03727053T ATE456956T1 AT E456956 T1 ATE456956 T1 AT E456956T1 AT 03727053 T AT03727053 T AT 03727053T AT 03727053 T AT03727053 T AT 03727053T AT E456956 T1 ATE456956 T1 AT E456956T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- photosensitized
- drugs
- delivering
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38147402P | 2002-05-16 | 2002-05-16 | |
| PCT/CA2003/000740 WO2003097096A1 (en) | 2002-05-16 | 2003-05-16 | Compositions and methods for delivery of photosensitive drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE456956T1 true ATE456956T1 (de) | 2010-02-15 |
Family
ID=29550129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03727053T ATE456956T1 (de) | 2002-05-16 | 2003-05-16 | Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7455858B2 (de) |
| EP (1) | EP1503796B1 (de) |
| AT (1) | ATE456956T1 (de) |
| AU (1) | AU2003233287A1 (de) |
| CA (1) | CA2484664C (de) |
| DE (1) | DE60331185D1 (de) |
| ES (1) | ES2341646T3 (de) |
| WO (1) | WO2003097096A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003000226A2 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions containing polymer and drug assemblies |
| US7133547B2 (en) | 2002-01-24 | 2006-11-07 | Tripath Imaging, Inc. | Method for quantitative video-microscopy and associated system and computer software program product |
| WO2005095950A1 (en) * | 2004-03-30 | 2005-10-13 | Pfizer Products Inc. | Method and device for evaluation of pharmaceutical compositions |
| US20060222592A1 (en) * | 2005-04-05 | 2006-10-05 | Clemens Burda | Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications |
| WO2006133271A2 (en) * | 2005-06-06 | 2006-12-14 | The General Hospital Corporation | Compositions and methods relating to target-specific photodynamic therapy |
| US20100119827A1 (en) * | 2006-04-25 | 2010-05-13 | Research Foundation Of The City University Of New York | Polymer submicron particle preparation by surfactant-mediated precipitation |
| WO2008065502A1 (en) * | 2006-11-29 | 2008-06-05 | Pfizer Products Inc. | Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein |
| US20100119612A1 (en) * | 2007-04-17 | 2010-05-13 | Bend Research, Inc | Nanoparticles comprising non-crystalline drug |
| US8703204B2 (en) * | 2007-05-03 | 2014-04-22 | Bend Research, Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer |
| US20100080852A1 (en) * | 2007-05-03 | 2010-04-01 | Ronald Arthur Beyerinck | Phamaceutical composition comprising nanoparticles and casein |
| WO2008135828A2 (en) * | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
| WO2008149230A2 (en) | 2007-06-04 | 2008-12-11 | Pfizer Products Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate |
| EP2162120B1 (de) * | 2007-06-04 | 2016-05-04 | Bend Research, Inc | Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer |
| US20100215747A1 (en) * | 2007-07-13 | 2010-08-26 | Corey Jay Bloom | Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers |
| WO2009073215A1 (en) * | 2007-12-06 | 2009-06-11 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
| EP2240162A4 (de) * | 2007-12-06 | 2013-10-09 | Bend Res Inc | Nanoteilchen mit einem nicht-ionisierbaren polymer und einem amin-funktionalisierten methacrylat-copolymer |
| EP2153821A1 (de) * | 2008-08-06 | 2010-02-17 | BioAlliance Pharma | Orale Formulierungen von Camptothecin-Derivaten |
| EP2198885B1 (de) | 2008-12-19 | 2012-02-08 | Biolitec AG | Kalziumphosphat-Nanopartikel als Farbstoffträger für die photodynamische Therapie |
| US8815931B2 (en) * | 2009-04-28 | 2014-08-26 | Biolitec Pharma Marketing Ltd | Oral formulations for tetrapyrrole derivatives |
| US20110275686A1 (en) | 2009-12-11 | 2011-11-10 | Biolitec, Inc. | Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt) |
| US9211283B2 (en) * | 2009-12-11 | 2015-12-15 | Biolitec Pharma Marketing Ltd | Nanoparticle carrier systems based on human serum albumin for photodynamic therapy |
| EP2741775B1 (de) * | 2011-08-11 | 2017-01-04 | Quest Pharmatech Inc. | Polymernanopartikel für photosensibilisatoren |
| EP2996677B1 (de) * | 2013-05-18 | 2019-11-20 | National Chung-Hsing University | Fotosensibilisatorteilchen für die medizinische bildgebung und/oder fotodynamische therapie |
| WO2015195458A1 (en) * | 2014-06-17 | 2015-12-23 | Albert Einstein College Of Medicine, Inc. | Therapeutic nanoparticles and methods thereof |
| WO2016054079A1 (en) | 2014-09-29 | 2016-04-07 | Zyomed Corp. | Systems and methods for blood glucose and other analyte detection and measurement using collision computing |
| WO2017015471A1 (en) | 2015-07-21 | 2017-01-26 | Avedro, Inc. | Systems and methods for treaments of an eye with a photosensitizer |
| US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4883790A (en) | 1987-01-20 | 1989-11-28 | University Of British Columbia | Wavelength-specific cytotoxic agents |
| US4968350A (en) | 1987-04-16 | 1990-11-06 | Christian Bindschaedler | Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powder and utilization thereof |
| US5798349A (en) | 1994-03-14 | 1998-08-25 | The General Hospital Corporation | Use of green porphyrins to treat neovasculature in the eye |
| US5707608A (en) * | 1995-08-02 | 1998-01-13 | Qlt Phototherapeutics, Inc. | Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer |
| CA2229285A1 (en) | 1995-09-21 | 1997-03-27 | Robert Gurny | Nanoparticles in photodynamic therapy |
| US20020127224A1 (en) | 2001-03-02 | 2002-09-12 | James Chen | Use of photoluminescent nanoparticles for photodynamic therapy |
-
2003
- 2003-05-15 US US10/440,505 patent/US7455858B2/en not_active Expired - Lifetime
- 2003-05-16 AU AU2003233287A patent/AU2003233287A1/en not_active Abandoned
- 2003-05-16 WO PCT/CA2003/000740 patent/WO2003097096A1/en not_active Ceased
- 2003-05-16 CA CA2484664A patent/CA2484664C/en not_active Expired - Fee Related
- 2003-05-16 AT AT03727053T patent/ATE456956T1/de not_active IP Right Cessation
- 2003-05-16 EP EP03727053A patent/EP1503796B1/de not_active Expired - Lifetime
- 2003-05-16 ES ES03727053T patent/ES2341646T3/es not_active Expired - Lifetime
- 2003-05-16 DE DE60331185T patent/DE60331185D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003097096A1 (en) | 2003-11-27 |
| DE60331185D1 (de) | 2010-03-25 |
| CA2484664A1 (en) | 2003-11-27 |
| US20040047913A1 (en) | 2004-03-11 |
| EP1503796B1 (de) | 2010-02-03 |
| EP1503796A1 (de) | 2005-02-09 |
| CA2484664C (en) | 2010-07-06 |
| US7455858B2 (en) | 2008-11-25 |
| AU2003233287A1 (en) | 2003-12-02 |
| ES2341646T3 (es) | 2010-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60331185D1 (de) | Zusammensetzungen und verfahren zur abgabe von photosensibilisierten arzneimitteln | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| CY1111263T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει sns-595 και χρησεις αυτης | |
| CY1106601T1 (el) | Χρηση του παραγωγου κουιναζολινης zd6474 συνδυασμενου με γκεμσιταμπινη και προαιρετικα με ιοντιζουσα ακτινοβολια στη θεραπεια του καρκινου | |
| LUC00011I1 (de) | ||
| SG166775A1 (en) | Combinations and modes of administration of therapeutic agents and combination therapy | |
| CY1110162T1 (el) | Φαρμακοτεχνικη μορφη και μεθοδοι για την αγωγη της θρομβοκυτταραιμιας | |
| DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
| DE60033649D1 (de) | Verbindungen und therapeutische methoden | |
| CY1113116T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης | |
| DE602004016754D1 (de) | Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839 | |
| ATE446763T1 (de) | Pharmazeutische formulierung zur behandlung von osteoarthritis mit clodronsäure und hyaluronsäure | |
| DE60334289D1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen | |
| ATE272400T1 (de) | Verwendung von tryptophan-derivaten zur spezifischen zytostatischen behandlung von serotonin-produzierenden tumoren | |
| ATE338560T1 (de) | Pharmazeutische zusammentsetzung zur medizinischen behandlung von gutartiger prostathyperplasie, dessen vorbereitungsmethode und dessen therapeutische verwendung | |
| ATE411313T1 (de) | Neue makrocyclen zur behandlung von krebserkrankungen | |
| DE60308127D1 (de) | Pharmazeutische Zusammentsetzung zur medizinischen Behandlung von gutartiger prostathyperplasie, dessen Vorbereitungsmethode und dessen therapeutische Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |